Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with Parkinson's disease that meets recognised medical diagnostic standards (either a confirmed or probable diagnosis).
- People of Chinese Han heritage (across three generations), aged between 50 and 80 years old, of any gender.
- People whose Parkinson's disease falls within a certain range of severity, from mild to moderately advanced stages (Hoehn-Yahr stages 1 to 4).
- People who have been on a stable dose of levodopa (a common Parkinson's medication) for at least three weeks before joining and throughout the study.
- People who are right-handed.
- People who have signed a written consent form agreeing to take part in the study.
Who may not be able to join:
- People whose symptoms resemble Parkinson's disease but are caused by a different underlying condition (not primary Parkinson's disease).
- People who have previously had brain surgery for Parkinson's disease, or who have received a type of brain stimulation treatment called TMS.
- People who have significant memory or thinking difficulties, based on a standard cognitive test score, or who are unable to complete the study assessments.
- People with intellectual or mental disabilities.
- People who are pregnant.
- People for whom the brain stimulation treatment used in this trial (rTMS) would be considered medically unsafe (confirm with trial site).
- People for whom an MRI scan would be considered medically unsafe (confirm with trial site).
- People who have a sleep disorder such as moderate to severe sleep apnoea, or who have a body mass index of 30 or above.
- People who regularly drink alcohol, or who are taking certain medications or consuming substances that may affect sleep patterns — including antidepressants (SSRIs or TCAs), sleeping tablets, or antihistamines (confirm with trial site for a full list).
- People who are unwilling to take part, unable to sign the consent form, or whom the research team considers unsuitable for other reasons.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaoying Zhu, doctor, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phone: +86 21 63240090
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of Motor Function in PD by Low Frequency rTMS Stimulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.